Clade I, the culprit in the current 2025 version of global epidemic mpox, is highly transmissible and is spreading within ...

Canada has an opportunity to prevent sustained Clade I mpox transmission, but only if decisive action is taken now.

Press Release - The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third ...

This new Clade I mpox is different from the version that ... lesions and also decreased shedding in the mouth and lungs of animals challenged with clade I monkeypox. What's more, Tonix reported ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the third meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...

Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company developing innovative vaccines, is advancing TNX-801, a live, minimally replicatin ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control among adults in an ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic. According to official data, there have been ...

Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...